Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict ...

Shares of Amgen Inc. AMGN slumped 0.21% to $265.95 Tuesday, on what proved to be an all-around dismal trading session for the ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the ...

The drug manufacturer Amgen announced Thursday it will invest another $1 billion and add 370 jobs to its future facility in ...

Amgen (AMGN) ended the recent trading session at $265.95, demonstrating a -0.21% swing from the preceding day's closing price. This change was narrower than the S&P 500's 0.39% loss on the day.

Amgen, a biotechnology company, announced last week that it will invest $1 billion in expanding its manufacturing facility in ...

Furthermore, the biotech's dividend program remains compelling despite near-term headwinds. Therefore, Amgen's combination of ...

Biopharma company Amgen plans to add 370 jobs as part of a new, $1.02 billion investment in Holly Springs. It’s the latest move by the company to expand manufacturing capacity in the fast ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in ...

Amgen’s decision to locate – and now expand – in Holly Springs fortifies the town’s and state’s reputations as ...